Clinical Trials Browser

Interventional × Malignant Solid Tumour × nintedanib × Clear all

NCT01951846 2013-09-27

To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour